x
Breaking News
0

Vertex Pharmaceuticals Inc (VRTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Vertex Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
156.19 -7.23    -4.42%
27/07 - Closed. Currency in USD ( Disclaimer )
After Hours
156.19
0.00
0.00%
27/07
Type: Equity
Market: United States
ISIN: US92532F1003 
CUSIP: 92532F100
  • Volume: 3,918,877
  • Bid/Ask: 154.10 / 164.00
  • Day's Range: 153.50 - 163.32
START TRADING NOW
Vertex Pharmaceuticals 156.19 -7.23 -4.42%

VRTX Overview

 
Information about the Vertex Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close163.42
Day's Range153.5 - 163.32
Revenue2.13B
Open160.88
52 wk Range71.46 - 167.85
EPS1.04
Volume3,918,877
Market Cap38.9B
Dividend (Yield)0 (N/A)
Average Vol. (3m)2,142,411
P/E Ratio149.68
Beta1.8
1-Year Change62.68%
Shares Outstanding250,770,000
Next Earnings DateJul 26, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Sell Buy Buy
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Buy Strong Buy
Summary Strong Sell Strong Sell Strong Sell Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Up 15 Current
Three Inside Up 1H Current
Completed Patterns
Bullish Engulfing 15 1 Jul 27, 2017 03:30PM
Engulfing Bearish 1D 2 Jul 25, 2017
Three Outside Down 30 5 Jul 27, 2017 01:00PM

Vertex Pharmaceuticals Inc News & Analysis

Vertex Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 156.19 154.10 164.00 3,918,877 -4.42% USD 27/07  
  Mexico 2,869.00 0.00 0.00 0 0.00% MXN 25/07  
  Berlin 132.740 132.590 133.770 0 -4.28% EUR 06:08:00  
  Stuttgart 132.487 132.572 133.761 202 +0.41% EUR 10:02:00  
  Munich 132.310 132.070 133.250 0 -3.85% EUR 06:00:00  
  Vienna 135.430 0.000 0.000 0 0.00% EUR 27/07  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Amazon.com 1,046.00 1,083.31 1,040.18 -6.80 -0.65% 10.99M 27/07  
  Apple 150.56 153.99 147.30 -2.90 -1.89% 32.48M 27/07  
  Facebook 170.44 175.49 167.50 +4.83 +2.92% 68.91M 27/07  
  Tesla 334.46 347.50 326.29 -9.39 -2.73% 8.30M 27/07  
  Intel 34.97 35.25 34.67 +0.22 +0.63% 43.06M 27/07  
  AMD 14.120 15.040 13.700 -0.640 -4.34% 130.30M 27/07  
  Alphabet A 952.51 969.52 937.06 -12.80 -1.33% 3.72M 27/07  
  NVIDIA 161.74 168.74 157.56 -5.52 -3.30% 19.57M 27/07  
  eBay 36.17 37.27 35.54 -0.87 -2.35% 15.29M 27/07  
  Alphabet Inc C 934.09 951.78 920.00 -13.71 -1.45% 3.21M 27/07  

Vertex Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

2150

Equity Type

ORD

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having two copies (homozygous) of the Delta-F508 (F508del) mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO (ivacaftor) is approved for the treatment of CF patients having the G551D mutation or other specified mutations in their CFTR gene. The Company's development programs in the field of CF include Tezacaftor (VX-661), VX-152, VX-440, VX-659, VX-445 and VX-371. VX-152, VX-440, VX-659 and VX-445 are CFTR corrector compounds.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email